IDenta Corp. (IDTA)

Market Cap	1.31M +8.0%
Revenue (ttm)	1.88M +57.5%
Net Income	141.05K
EPS	0.02
Shares Out	4.37M
PE Ratio	13.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,500
Open	0.3000
Previous Close	n/a
Day's Range	0.3000 - 0.3000
52-Week Range	0.1511 - 0.4826
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 18, 2026

About IDenta

IDenta Corp. operates as a detection and forensic science company. The company offers drug, and explosives testing kits; aero chamber sniffer; forensic; and urine, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Australia, Canada, and inte...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2002
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDTA

Financial Performance

In 2025, IDenta's revenue was $1.34 million, a decrease of -7.86% compared to the previous year's $1.46 million. Earnings were $99,044, a decrease of -61.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 21, 2026

Data Sources Report a data error